| |
| |
|
| Insider
Information: |
Bonita David P |
| Relationship: |
Director, 10% Owner |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
74,794 |
|
|
Indirect Shares
|
56,864,196 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$82,236,293 |
|
|
| Total
Shares |
56,938,990 |
|
|
| Total
Value |
$82,236,293 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 29.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Loxo Oncology, Inc. |
LOXO |
Director |
2014-08-06 |
0 |
2017-12-08 |
941,000 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Director, 10% Owner |
2017-11-15 |
26,388 |
2017-11-15 |
9,458,567 |
Premium* |
|
|
Tricida, Inc. |
TCDA |
Director, 10% Owner |
2021-11-15 |
27,584 |
2021-11-15 |
10,280,947 |
Premium* |
|
|
Si-Bone, Inc. |
SIBN |
Director |
2018-10-19 |
0 |
2018-10-19 |
985,368 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
Director, 10% Owner |
2020-03-12 |
0 |
2021-07-16 |
4,199,068 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
0 |
2021-09-07 |
96,190 |
Premium* |
|
|
Acutus Medical, Inc. |
AFIB |
Director |
2023-06-15 |
20,822 |
2022-06-16 |
6,549,386 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
Director, 10% Owner |
|
0 |
2023-05-22 |
10,646,056 |
Premium* |
|
|
Ikena Oncology, Inc. |
IKNA |
Director |
2021-03-30 |
0 |
2023-08-04 |
7,928,543 |
Premium* |
|
|
Third Harmonic Bio, Inc. |
THRD |
Director, 10% Owner |
2022-09-19 |
0 |
2022-09-19 |
5,779,071 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LOXO |
Loxo Oncology, Inc. |
Director |
– • • |
2014-08-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,900,472 |
1,900,472 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • • |
2014-08-06 |
4 |
B |
$13.00 |
$3,580,005 |
I/I |
275,385 |
2,175,857 |
2.25 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • • |
2016-03-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,989,916 |
|
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2016-08-10 |
4 |
S |
$26.96 |
$12,074,225 |
I/I |
(447,857) |
1,728,000 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • • |
2016-08-22 |
4 |
B |
$2.95 |
$3,357,318 |
I/I |
1,138,074 |
86,107 |
2.25 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • • |
2016-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
19,531 |
19,531 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • • |
2017-01-18 |
4 |
B |
$3.00 |
$991,731 |
I/I |
330,577 |
89,225 |
2.25 |
- |
|
| VRAY |
Viewray, Inc. |
Director |
– • • |
2017-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,857 |
26,388 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2017-11-16 |
4 |
S |
$72.46 |
$20,051,389 |
I/I |
(270,000) |
1,458,000 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2017-11-22 |
4 |
S |
$75.00 |
$20,025,000 |
I/I |
(267,000) |
1,191,000 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2017-12-08 |
4 |
S |
$82.50 |
$20,625,000 |
I/I |
(250,000) |
941,000 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
|
• • • |
2018-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,632 |
3,632 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
|
• • • |
2018-07-02 |
4 |
B |
$19.00 |
$6,999,999 |
I/I |
368,421 |
10,889,280 |
0.01 |
- |
|
| TCDA |
Tricida, Inc. |
|
• • • |
2018-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
10,520,859 |
10,520,859 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
Director |
– • – |
2018-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
785,368 |
785,368 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
Director |
– • – |
2018-10-19 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
985,368 |
2.1 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • • |
2019-04-03 |
4 |
B |
$36.00 |
$8,100,000 |
I/I |
225,000 |
11,114,280 |
2.25 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • • |
2019-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,879 |
5,511 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • • |
2019-12-11 |
4 |
S |
$40.00 |
$60,000,000 |
I/I |
(1,500,000) |
9,614,280 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • • |
2020-03-12 |
4 |
B |
$16.00 |
$15,000,000 |
I/I |
937,500 |
937,500 |
2.25 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,594,902 |
2,532,402 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • • |
2020-06-11 |
4 |
A |
$0.00 |
$0 |
I/I |
5,670 |
11,181 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2020-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
2,601,325 |
2,601,325 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
Director |
– • – |
2020-06-23 |
4 |
B |
$20.00 |
$15,484,000 |
I/I |
774,200 |
99,200 |
2.1 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director |
– • – |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,222 |
2,222 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
